Financials data is unavailable for this security.
View more
Year on year Assembly Biosciences Inc grew revenues -- from 0.00 to 7.16m while net income improved from a loss of 93.09m to a smaller loss of 61.23m.
Gross margin | -- |
---|---|
Net profit margin | -144.05% |
Operating margin | -163.94% |
Return on assets | -53.73% |
---|---|
Return on equity | -120.51% |
Return on investment | -79.14% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Assembly Biosciences Inc fell by 32.58m. However, the company earned 22.74m from its operations for a Cash Flow Margin of 317.51%. In addition the company generated 13.82m cash from financing while 69.14m was spent on investing.
Cash flow per share | -7.37 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.09 |
---|---|
Tangible book value per share | 4.09 |
More ▼
Balance sheet in USDView more
Current ratio | 2.36 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼